A&G Pharmaceutical is a pioneering theranostics company that focuses on developing monoclonal antibodies targeting cancer-specific markers for both therapeutic and diagnostic purposes. The company's innovative approach to utilizing its patented growth factor, GP88, has led to the advancement of diagnostic test kits specifically designed for the early detection, diagnosis, and treatment of breast cancer. In addition to its diagnostic products, A&G's therapeutic division is dedicated to developing anti-GP88 monoclonal antibody treatments for cancer. The company generates revenue through its customized antibody service, which expedites the creation of novel antibody therapeutics for leading pharmaceutical and biotechnology firms, as well as federal laboratories. A&G Pharmaceutical was founded in 2000 and has successfully raised $3.5 million in equity capital. Based in Columbia, Maryland, the company received a $100.00K Venture Round investment on 27 April 2010.
A&G Pharmaceutical, Inc.
Pioneering the future of cancer treatment and diagnostics through innovative monoclonal antibody development.
Columbia, United States
8 employees
Series Unknown
Total: $2.10M
Biotechnology, Health and Wellness +1
General Information
Get notified when A&G Pharmaceutical, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track A&G Pharmaceutical, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biotechnology
About A&G Pharmaceutical, Inc.
Taxonomy: monoclonal antibodies, cancer treatment, diagnostics, theranostics, drug development, cancer-specific markers, breast cancer, GP88 growth factor, equity capital, scientific research, biopharmaceuticals
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 27 Apr 2010 | |
| Series A | •••••• | 3 |
|
08 Sep 2005 |
A&G Pharmaceutical, Inc. Alternatives & Competitors
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “In...
Pioneering advanced treatments for cancer with innovative therapeutic antibodies and drug conjugates...
Reducing the timeline to produce mAb from months to days.
FAQ About A&G Pharmaceutical, Inc.
Don't just browse. Track.
Signal Tracker monitors A&G Pharmaceutical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.